Fungal diseases in small mammals: Therapeutic trends and zoonotic considerations

Veterinary Clinics of North America - Exotic Animal Practice

Volumn 6, Issue 2, 2003, Pages 415-427

  Marshall, Kemba L ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; ARTEMISIA EXTRACT; CAPTAN; CURCUMA LONGA EXTRACT; DERMATOPHYTE IV; ECHINOCANDIN DERIVATIVE; FLUCONAZOLE; FUNGUS VACCINE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; LACTOFERRIN; MICONAZOLE; NIKKOMYCIN Z; OMEPRAZOLE; OMOCONAZOLE NITRATE; ORTHOCAPTAN; PLANT MEDICINAL PRODUCT; PNEUMOCANDIN DERIVATIVE; POSACONAZOLE; PSEUDOMONIC ACID; PYRROLE DERIVATIVE; RAVUCONAZOLE; SELENIUM SULFATE; SORDARIN DERIVATIVE; SULFUR DERIVATIVE; TOLNAFTATE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORICONAZOLE;

ANIMAL DISEASE; ASPERGILLOSIS; CANDIDIASIS; DERMATOMYCOSIS; DIAGNOSTIC PROCEDURE; DISEASE CARRIER; DRUG ACCUMULATION; DRUG CROSS REACTIVITY; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SOLUBILITY; FUNGUS CULTURE; GERBIL; GUINEA PIG; HEDGEHOG; HOST RANGE; HUMAN; IMMUNE DEFICIENCY; MAMMAL; MEDICAL RESEARCH; MICROSCOPY; MUCORMYCOSIS; MYCOSIS; NONHUMAN; REVIEW; SKIN EXAMINATION; ZOONOSIS;

ANIMALIA; ARTEMISIA; CAVIA PORCELLUS; CURCUMA; CURCUMA LONGA; ERINACEIDAE; FUNGI; GERBILLINAE; MAMMALIA; SUS SCROFA;

EID: 0037672740     PISSN: 10949194     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1094-9194(03)00002-1     Document Type: Review

References (50)

1. Richard J, Debey M, Chermette R, et al. Advances in veterinary mycology. J Med Vet Mycol 1994;32(1):169-87.
2. Liu D, Pearce L, Lilley G, et al. Specific PCR assay will be the dermatophyte fungus microspurum kennels. Med Mycol 2001;39:215-19.
3. Wakabayashi H, Uchida K, Yamauchi K, et al. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicro Chemo 2000;46:595-601.
4. Scott D, Miller W, Griffin C. Fungal skin diseases. In: Scott D, Miller W, Griffin C, editors. Muller and Kirk's small animal dermatology. 5th edition. Philadelphia: WB Saunders; 1995. p. 329-91.
5. Donnelly T, Rush E, Lackner P. Ringworm in small exotic pets. Sem Avian Exotic Pet Med 2000;9(2):82-93.
6. Pier A, Hodges A, Lauze J, et al. Experimental immunity to Microsporum canis and cross reactions with other dermatophytes of veterinary importance. J Med Vet Mycol 1995; 33:93-7.
7. Weitzman I, Summerbell R. The dermatophytes. Clin Micro Rev 1995;8:240-59.
8. Jones H. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol 1993;28:S12-8.
9. Poulain D, Tronchin G, Vernes A, et al. Experimental study of resistance to infection by Trichophyton mentagrophytes: demonstration of memory skin cells. J Invest Dermatol 1980; 74:205-9.
10. Scott D, Miller W, Griffin C. Dermatoses of pet rodents, rabbits and ferrets. In: Scott D, Miller W, Griffin C, editors. Muller and Kirk's small animal dermatology. 6th edition. Philadelphia: WB Saunders; 2001. p. 1415-58.
11. Hashiguchi T, Ryu A, Itoyama T, et al. Study of the effective dose of a topical antifungal agent omoconazole nitrate, on the basis of percutaneous pharmacokinetics in guinea pigs and mice. J Pharm Pharmacol 1997;49(8):757-61.
12. Freedman M, Baxter R, Walker G. In vitro sorption of griseofulvin by keratin substrate. J Invest Dermatol 1962;38:199-208.
13. Arika T, Hase T, Yokoo M. Activity of topical antifungals on infected sites: skin permeability and adsorption to horny materials. Nishinihon J Dermatol 1990;52:545-9.
14. Aljagre S, Scott A, Shankland G, et al. In vitro susceptibility of Trichophyton mentagrophytes anthroconidia to clotrimazole and griseofulvin in human corneocyte suspensions. Mycoses 1991;34:479-82.
15. Nicholas R, Berry V, Hunter P, et al. The antifungal activity of mupirocin. J Antimicrob Chemo 1999;43:579-82.
16. Polak A. Preclinical data and mode of action of amorolfine. Dermatology 1992;184(1):3-7.
17. Polak A. Preclinical data and mode of action of amorolfine. Clin Experim Dermatol 1992; 17(1):8-12.
18. Zaug M, Bergstraesser M. Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview). Clin Exper Dermatol 1992;17(1):61-70.
19. Degreef H, DeDoncker P. Current therapy of dermatophytosis. J Antimicro Chemo 1994;31(pt 2):3.
20. Nagino K, Shimohira H, Ogawa M, et al. Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis. J Antibio 2000;53(2):207-10.
21. Hay R. Pharmacokinetic evaluation of fluconazole in skin and nails. Inter J Dermatol 1992;31(2):6-7.
22. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exper Dermatol 1993;18: 102-6.
23. Wildfeuer A, Faergemann H, Laufen H, et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994;37:127-30.
24. Ernst E. Investigational antifungal agents. Pharmacotherapy 2001;21(8):165S:74.
25. Kishore N, Dubey N, Chansouria J. Antimycotic activity of the essential oil of Artemisia nilagirica. Flavour Fragr J 2001;16:61-3.
26. Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharm 1995;49:163-9.
27. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995;16:417-9.
28. Percy DH, Barthold SW. Pathology of laboratory rodents and rabbits. Ames(IA): Iowa State University Press; 1993.
29. Huerkamp MJ, Murray KA, Orosz SE. Guinea pigs. In: Laber-Laird K, Swindle MM, Flecknell PA, editors. Handbook of rodent and rabbit medicine. Exeter (UK): BPC Wheatons; 1996. p. 91-150.
30. Schaeffer DO, Donnelly TM. Disease problems of guinea pigs and chinchillas. In: Hillyer EV, Quesenberry KE, editors. Ferrets, rabbits, and rodents. Clinical medicine and surgery. Philadelphia: WB Saunders; 1997. p. 307-28.
31. Harkness JE, Wagner JE. Clinical signs and differential diagnosis: the biology and medicine of rabbits and rodents. 4th edition. Baltimore: Williams & Wilkins; 1995. p. 155-158.
32. Ellis C, Mori M. Skin diseases of rodents and small exotic mammals. Vet Clin N Am: Exot Anim Pract 2001;(4):493-542.
33. Hoefer HL, Crossley DA. Chinchillas. In: Meredith A, Redrobe S, editors. BSAVA manual of exotic pets. 4th edition. Gloucester, UK: British Small Animal Veterinary Association; 2002. p. 65-75.
34. Johnson-Delaney CA. Exotic companion medicine handbook for veterinarians: small rodents. Lake Worth (FL): Wingers Publishing; 1996.
35. Hoefer HL. Clinical approach to the African hedgehog. North American Veterinary Conference Proceedings, Eastern States Veterinary Association, Gainesville (FL): Eastern States Veterinary Association; 1999. p. 836-8.
36. Larson RS, Carpenter JW. Husbandry and medical management of African hedgehogs. Vet Med 1999;94:877-90.
37. Campbell T. Intestinal candidiasis in an African hedgehog (Atelerix albiventris). Exotic Pet Pract 1997;2(10):79.
38. English M, Gregory M, Spence J. Invasion by Candida albicans of the footpads of the central African hedgehog (Erinaceus albiventris). Mycopathologia 1975;55(3):139-41.
39. Clemons K, et al. Pathogenesis I: interactions of host cells and fungi. Med Mycol 2000;38(1):99-111.
40. Pfaller M, Messer L, Hollis R, et al. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotercin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program. Antimicrob Agents Chemo 2000;46:1032-7.
41. Kirkpatrick W, Perea S, Coco B, et al. Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspegillosis. J Antimicrob Chemo 2002;49:353-7.
42. Overdijk B, Van Steijn GJ, Odds FC. Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus. Glycobiology 1996;6(6):627-4.
43. Martin M, Yates J, Hitchcock C. Comparison of voriconazole (UK-109, 496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob Agents Chemo 1997;41(1):13-6.
44. Chandrasekar P, Cutright J, Manavathu E. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea pig model. J Antimicrob Chemo 2000;45:673-6.
45. Sugar A, Liu X-P. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med Mycol 2000;38:209-12.
46. Richardson MD, Shankland GS. Rhizopus, Rhizomucor, Absidia, and other agents of systemic and subcutaneous zygomycoses. In: Murray PR, Baron EJ, Pfaller MA, et al, editors. Manual of clinical microbiology. 7th edition. Washington, DC: ASM Press; 1999. p. 1242-58.
47. Kamei K. Animal models of zygomycosis- Absidia, Rhizopus, Rhizomucor and Cunninghamella. Mycopathologia 2000;152:5-13.
48. Diamond R, Krzesicki R, Epstein B, et al. Damage to hyphal forms of fungi by human leukocytes in vitro-A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol 1978;91:313-28.
49. Boelaert J, de Locht M, van Custem J, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: in vitro and in vivo studies. J Clin Invest 1993;91: 1979-86.
50. Bartsch R, Green R. New treatment of coccidiomycosis. Vet Forum. 1997;50-2.